BFC Planning’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
BFC Planning's CLB Position: Q3 2026 in Review
BFC Planning increased its Core Laboratories (CLB) stake by 28% in Q3 2026, buying an estimated $671 and bringing the position to 267 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.
BFC Planning first reported a position in CLB in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.51K in Q1 2026. 131 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- BFC Planning held 267 shares of Core Laboratories worth $2.59K as of Q3 2026.
- BFC Planning bought 58 Core Laboratories shares in Q3 2026, an estimated $671.
- Core Laboratories made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2932 holding.
- BFC Planning first reported a position in Core Laboratories in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Core Laboratories position peaked at $3.51K in Q1 2026.
- 131 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.